General Information of the Compound
Compound ID
CP0550734
Compound Name
5-ethyl-4-[4-[(2-methylphenyl)methyl]-3-oxopiperazin-1-yl]-1H-pyridazin-6-one
    Show/Hide
Structure
Formula
C18H22N4O2
Molecular Weight
326.4
Canonical SMILES
CCc1c(cn[nH]c1=O)N1CCN(Cc2ccccc2C)C(=O)C1
    Show/Hide
InChI
InChI=1S/C18H22N4O2/c1-3-15-16(10-19-20-18(15)24)21-8-9-22(17(23)12-21)11-14-7-5-4-6-13(14)2/h4-7,10H,3,8-9,11-12H2,1-2H3,(H,20,24)
    Show/Hide
InChIKey
NAORZVNLFXHGMH-UHFFFAOYSA-N
Physicochemical Property
logP
1.48952
Rotatable Bonds
4
Heavy Atom Count
24
Polar Areas
69.3
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 155536492
ChEMBL ID
CHEMBL4473219
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05452, Short transient receptor potential channel 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 11000 nM
   TI
   LI
   LO
   TS